Hrt Financial LP Mei Pharma, Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.33 - $3.37 $190,013 - $274,826	-81,551 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.52 - $2.99 $71,565 - $84,913	28,399 Added 53.43%	81,551 $225,000
Q2 2021 Aug 16, 2021	BUY	$2.6 - $3.65 $138,195 - $194,004	53,152 New	53,152 $151,000
Q3 2019 Nov 14, 2019	SELL	$1.48 - $2.52 $74,657 - $127,118	-50,444 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.45 - $3.32 $123,587 - $167,474	50,444 New	50,444 $126,000

Ticker MEIP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 133,261,000
Market Cap $372M
Description
MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.